Registration
CAPITOL COUNSEL LLC for BOEHRINGER INGELHEIM ANIMAL HEALTH US
Firm
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Animals ANI
Issues regarding FDA animal drug approval process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN New | Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton. |
Medical/Disease Research/Clinical Labs MED
Issues regarding FDA animal drug approval process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN New | Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton. |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH | Germany | Germany | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.